Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings yield is N/A as of 2026-10-06T19:58:13.766Z.
Calculation as of: 2026-10-06T19:58:13.766Z.
Quote observation: 2026-10-06T19:55:24.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 733e4da94f9494cd21c7af02f5120fd8528014c079e3dffba0957966aae51245
EARNINGS YIELD
N/A
Market Cap
$18.62M
Earnings Yield
N/A
TTM Avg
66.69%
3Y Avg
66.69%
5Y Avg
66.69%
Market Cap
$18.18M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| NextCure, Inc. (NXTC) | $19.45M | N/A | N/A | N/A | N/A |
| Actuate Therapeutics Inc (ACTU)vs › | $19.28M | N/A | N/A | N/A | N/A |
| Quantum BioPharma Ltd. (QNTM)vs › | $19.71M | N/A | N/A | N/A | N/A |
| P3 Health Partners Inc. (PIII)vs › | $18.77M | N/A | N/A | N/A | N/A |
| Neuphoria Therapeutics Inc. (NEUP)vs › | $18.62M | N/A | 66.69% | 66.69% | 66.69% |
| Estrella Immunopharma, Inc. (ESLA)vs › | $18.18M | N/A | N/A | N/A | N/A |
| Cosmos Health Inc. (COSM)vs › | $17.32M | N/A | 2.31% | 2.31% | 2.31% |
| PAVmed Inc. (PAVM)vs › | $17.20M | N/A | 194.82% | 194.82% | 194.82% |
| Lipocine Inc. (LPCN)vs › | $17.19M | N/A | 0.00% | 5.85% | 5.85% |
| Palatin Technologies, Inc. (PTN)vs › | $17.14M | N/A | 16.05% | 16.05% | 16.05% |
Earnings Yield
N/A
EPS ÷ Price
P/E Ratio
N/A
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
